5,6-Dibromo-N-methyltryptamine
Chemical compound
| Chemical Compound | |
|---|---|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider ID | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| Properties | |
| Chemical Formula | |
| Molar Mass | |
| Appearance | |
| Density | |
| Melting Point | |
| Boiling Point | |
| Hazards | |
| GHS Pictograms | [[File:|50px]] |
| GHS Signal Word | |
| GHS Hazard Statements | |
| NFPA 704 | [[File:|50px]] |
| References | |
5,6-Dibromo-N-methyltryptamine (5,6-diBr-NMT) is a chemical compound belonging to the class of tryptamines. It is a derivative of N-methyltryptamine (NMT) with two bromine atoms substituted at the 5 and 6 positions of the indole ring.
Chemical structure and properties
5,6-Dibromo-N-methyltryptamine is characterized by the presence of a bromine atom at both the 5 and 6 positions of the indole ring, which is a common structural motif in tryptamine derivatives. The compound has the molecular formula C11H12Br2N2.
The presence of bromine atoms significantly alters the electronic properties of the indole ring, potentially affecting the compound's pharmacology and biological activity.
Synthesis
The synthesis of 5,6-dibromo-N-methyltryptamine typically involves the bromination of N-methyltryptamine. This process can be achieved through the use of brominating agents such as bromine or N-bromosuccinimide (NBS) under controlled conditions to ensure selective substitution at the 5 and 6 positions.
Pharmacology
As a tryptamine derivative, 5,6-dibromo-N-methyltryptamine may interact with serotonin receptors in the brain. However, specific pharmacological data on this compound is limited, and its effects on the human body are not well-documented.
Potential applications
Research into 5,6-dibromo-N-methyltryptamine and similar compounds may provide insights into the development of new psychoactive drugs or therapeutic agents. The unique substitution pattern of bromine atoms could lead to novel interactions with biological targets.
Safety and legal status
The safety profile of 5,6-dibromo-N-methyltryptamine is not well-established, and it is not widely used in clinical or recreational settings. The legal status of this compound may vary by jurisdiction, and it is important to consult local regulations before handling or experimenting with it.
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian